Global consensus recommendations on Sculptra® published in JDD

European expert recommendations for the use of Poly-L-Lactic Acid (PLLA, Sculptra®, Sinclair Pharmaceuticals) have been published in the Journal of Drugs and Dermatology (JDD).

The review presents recommendations on the ideal use of the collagen stimulator for facial rejuvenation lasting up to 25 months. Alongwith the US consensus, publishedin the journal in April 2014, there commendations provide a global consensus in the optimisation of Sculptra® use and safety. The review, based on the recommendations of the European Expert Group, documents that optimal results with Sculptra® are achieved based on a detailed knowledge of facial anatomy, correct treatment procedure, specifically the right dilution, the correct injection technique and appropriate aftercare.

Dr Linda Eve, senior trainer and chairman of the UK Sculptra® Advisory Board and member of the European Expert Group, said,“ I am delighted to have been a member of the Sculptra® European Expert Board and to have worked closely together to produce the recent publication in the JDD. We now have excellent European guidelines for the usage and safety of Sculptra®, which together with the US Consensus, provides a solid and comprehensive global understanding of the benefits and application of this unique and extremely effective collagen-stimulating product. ”